N‐terminal modification of an LAH4‐derived peptide increases mRNA delivery in the presence of serum - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Peptide Science Année : 2024

N‐terminal modification of an LAH4‐derived peptide increases mRNA delivery in the presence of serum

Résumé

The recently developed mRNA-based coronavirus SARS-CoV-2 vaccines highlighted the great therapeutic potential of the mRNA technology. Although the lipid nanoparticles used for the delivery of the mRNA are very efficient, they showed, in some cases, the induction of side effects as well as the production of antibodies directed against particle components. Thus, the development of alternative delivery systems is of great interest in the pursuit of more effective mRNA treatments. In the present work, we evaluated the mRNA transfection capacities of a series of cationic histidine-rich amphipathic peptides derived from LAH4. We found that while the LAH4-A1 peptide was an efficient carrier for mRNA, its activity was highly serum sensitive. Interestingly, modification of this cell penetrating peptide at the N-terminus with two tyrosines or with salicylic acid allowed to confer serum resistance to the carrier. Keywords: LAH4 peptide family; amphipathic peptide; cell penetrating peptide; gene delivery; mRNA transfection.
Fichier principal
Vignette du fichier
islandora_170420.pdf (2.32 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04522663 , version 1 (26-03-2024)

Identifiants

Citer

Candice Dussouillez, Morane Lointier, Mohammed-Karim Sebane, Sylvie Fournel, Burkhard Bechinger, et al.. N‐terminal modification of an LAH4‐derived peptide increases mRNA delivery in the presence of serum. Journal of Peptide Science, 2024, in press, ⟨10.1002/psc.3597⟩. ⟨hal-04522663⟩
0 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More